Literature DB >> 14744970

Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).

Philippe Gabriel Steg1, Omar H Dabbous, Laurent J Feldman, Alain Cohen-Solal, Marie-Claude Aumont, José López-Sendón, Andrzej Budaj, Robert J Goldberg, Werner Klein, Frederick A Anderson.   

Abstract

BACKGROUND: Few data are available on the impact of heart failure (HF) across all types of acute coronary syndromes (ACS). METHODS AND
RESULTS: The Global Registry of Acute Coronary Events (GRACE) is a prospective study of patients hospitalized with ACS. Data from 16 166 patients were analyzed: 13 707 patients without prior HF or cardiogenic shock at presentation were identified. Of these, 1778 (13%) had an admission diagnosis of HF (Killip class II or III). HF on admission was associated with a marked increase in mortality rates during hospitalization (12.0% versus 2.9% [with versus without HF], P<0.0001) and at 6 months after discharge (8.5% versus 2.8%, P<0.0001). Of note, HF increased mortality rates in patients with unstable angina (defined as ACS with normal biochemical markers of necrosis; mortality rates: 6.7% with versus 1.6% without HF at admission, P<0.0001). By logistic regression analysis, admission HF was an independent predictor of hospital death (odds ratio, 2.2; P<0.0001). Admission HF was associated with longer hospital stay and higher readmission rates. Patients with HF had lower rates of catheterization and percutaneous cardiac intervention, and fewer received beta-blockers and statins. Hospital development of HF (versus HF on presentation) was associated with an even higher in-hospital mortality rate (17.8% versus 12.0%, P<0.0001). In patients with HF, in-hospital revascularization was associated with lower 6-month death rates (14.0% versus 23.7%, P<0.0001; adjusted hazard ratio, 0.5; 95% CI, 0.37 to 0.68, P<0.0001).
CONCLUSIONS: In this observational registry, heart failure was associated with reduced hospital and 6-month survival across all ACS subsets, including patients with normal markers of necrosis. More aggressive treatment of these patients may be warranted to improve prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 14744970     DOI: 10.1161/01.CIR.0000109691.16944.DA

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  106 in total

Review 1.  The role of radionuclide imaging in heart failure.

Authors:  Vinay Gulati; Gilbert Ching; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

2.  Long term prognosis of heart failure after acute coronary syndromes without ST elevation.

Authors:  M C Shibata; J Collinson; A K Taneja; A Bakhai; M D Flather
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 3.  Heart failure and shock complicating acute coronary syndromes.

Authors:  Frederick A Spencer; Theo Meyer
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

Review 4.  Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.

Authors:  David H Fitchett; Bjug Borgundvaag; Warren Cantor; Eric Cohen; Sanjay Dhingra; Stephen Fremes; Milan Gupta; Michael Heffernan; Heather Kertland; Mansoor Husain; Anatoly Langer; Eric Letovsky; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

Review 5.  Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies.

Authors:  G A Whalley; G D Gamble; R N Doughty
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

6.  Assessment of left ventricular function in older Medicare beneficiaries with newly diagnosed heart failure.

Authors:  Lesley H Curtis; Melissa A Greiner; Alisa M Shea; David J Whellan; Bradley G Hammill; Kevin A Schulman; Pamela S Douglas
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

7.  Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.

Authors:  Mohammad I Zia; Shaun G Goodman; Eric D Peterson; Jyotsna Mulgund; Anita Y Chen; Anatoly Langer; Mary Tan; E Magnus Ohman; W Brian Gibler; Charles V Pollack; Matthew T Roe
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

Review 8.  Explicit risk in acute coronary syndrome management.

Authors:  Merril L Knudtson; Colleen M Norris; P Diane Galbraith; Jaro Hubacek; William A Ghali
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

9.  beta-Adrenergic receptor blockers and heart failure risk after myocardial infarction: a critical review.

Authors:  Robert H Neumayr; Paul J Hauptman
Journal:  Curr Heart Fail Rep       Date:  2009-12

10.  Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo.

Authors:  Nathan J Palpant; Louis G D'Alecy; Joseph M Metzger
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.